AlerisLife Inc. Announces Annual Meeting Results

NEWTON, Mass.--(BUSINESS WIRE)-- AlerisLife Inc. (Nasdaq: ALR) announced the results of its 2022 Annual Meeting of Stockholders which was held today.

Bruce M. Gans, M.D. was re-elected as an Independent Director. The final tabulation of the percentage of stockholders’ votes cast for this Independent Director is as follows:

Independent Director					Percentage of Shares Voted For
Bruce M. Gans					81.3%

Michael E. Wagner, M.D. was re-elected as Independent Director. The final tabulation of the percentage of stockholders’ votes cast for this Independent Director is as follows:

Independent Director					Percentage of Shares Voted For
Michael E. Wagner					81.5%

Jennifer B. Clark was re-elected as Managing Director. The final tabulation of the percentage of stockholders’ votes cast for this Managing Director is as follows:

Managing Director					Percentage of Shares Voted For
Jennifer B. Clark					95.7%

Stockholders voted to approve the Second Amended and Restated 2014 Equity Compensation Plan. The final tabulation of the percentage of stockholders’ votes cast for this proposal is as follows:

Proposal						Percentage of Shares Voted For
Approval of executive compensation plan						79.7%

Stockholders ratified the appointment of Deloitte & Touche LLP as AlerisLife Inc.’s independent auditors to serve for the 2022 fiscal year. The final tabulation of the percentage of stockholders’ votes cast for this proposal is as follows:

Proposal						Percentage of Shares Voted For
Ratification of Independent Auditors						99.0%

About AlerisLife (Nasdaq: ALR)

AlerisLife enriches and inspires the lives of its older adult customers across the United States by delivering an exceptional and enhanced resident experience to senior living and active adult residents, while also offering lifestyle services to the younger, choice-based consumer. The company is headquartered in Newton, Massachusetts. For more information, visit www.alerislife.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220607006129/en/

Michael Kodesch, Director, Investor Relations

(617) 796-8234

Source: AlerisLife